646
Participants
Start Date
June 20, 2011
Primary Completion Date
September 2, 2014
Study Completion Date
April 21, 2021
Lenalidomide
Capsules, Oral, 25 mg, once daily, on Days 1-21, Repeat every 28 days until subject meets criteria for discontinuation of study drug
Dexamethasone
Tablets, Oral, 40 mg, weekly, on Days 1, 8, 15, 22, Repeat every 28 days until subject meets criteria for discontinuation of study drug
Dexamethasone (Oral)
"On weeks without Elotuzumab dosing: Tablets, Oral, 40mg, Repeat every 28 days until subject meets criteria for discontinuation of study drug.~On weeks with Elotuzumab dosing: Tablets, Oral, 28 mg, Repeat every 28 days until subject meets criteria for discontinuation of study drug"
Dexamethasone (IV)
"On weeks without Elotuzumab dosing: Not Applicable (N/A)~On weeks with Elotuzumab dosing: Solution, Intravenous (IV), 8 mg, weekly, Repeat every 28 days until subject meets criteria for discontinuation of study drug"
Elotuzumab (BMS-901608; HuLuc63)
Solution, IV, 10 mg/kg, weekly, on Days 1, 8, 15, 22 (cycles 1\&2); Days 1 and 15 (cycles 3 and beyond), Repeat every 28 days until subject meets criteria for discontinuation of study drug
Local Institution, Dublin
Local Institution, Brussels
Local Institution, Brussels
Local Institution, Brussels
Local Institution, Budapest
Local Institution, Brussles
Local Institution, Geneva
Local Institution, Vienna
Local Institution, Antwerp
Local Institution, Copenhagen
Local Institution, Canberra
Local Institution, Albury
Local Institution, Edegem-antwerp
Local Institution, Melbourne
Local Institution, Bern
Local Institution, Malvern
Local Institution, Liège
Local Institution, South Brisbane
Local Institution, Steyr
Local Institution, Wels
Local Institution, Adelaide
Local Institution, Odense C
Local Institution, Yvoir
Local Institution, Nedlands
Local Institution, Murdoch
Local Institution, Rankweil
Local Institution, Vejle
Local Institution, Győr
NYU Clinical Cancer Center, New York
Local Institution, New York
Weill Cornell Medical College, New York
Local Institution, Torino
Local Institution, Athens
Local Institution, Berlin
Local Institution, Berlin
Local Institution, Caen
Western Pennsylvania Hospital, Pittsburgh
Local Institution, Santiago de Comp-coruna
Local Institution, Genova
Local Institution, Bethlehem
Local Institution, Afula
Local Institution, Milan
Local Institution, Hamburg
Local Institution, Bucharest
Hematology-Oncology Associates Of Fredricksburg, Inc, Fredericksburg
Local Institution, Hamburg
Local Institution, Kiel
Local Institution, Bergamo
Local Institution, Madrid
Local Institution, Madrid
Gaston Hematology & Oncology, Gastonia
Levine Cancer Institute, Charlotte
Local Institution, Charleston
Local Institution, Greenville
Local Institution, Murcia
Winship Cancer Institute., Atlanta
Georgia Health Science University, Augusta
Local Institution, Toulouse
Local Institution, Titusville
Cancer Institute Of Florida, Orlando
Local Institution, Bordeaux
Mount Sinai Comprehensive Cancer Center, Miami Beach
Florida Cancer Specialists, West Palm Beach
Local Institution, Boca Raton
Local Institution, Istanbul
Cancer Care Centers Of Florida, Brooksville
Local Institution, New Port Richey
Local Institution, Marburg
Local Institution, Izmir
Local Institution, Izmir
Northwest Alabama Cancer Center, Pc, Muscle Shoals
Local Institution, Salamanca
Local Institution, Tours
Local Institution, Knoxville
The West Clinic, Memphis
Local Institution, La Tronche
Local Institution, Bologna
Local Institution, Louisville
Local Institution, Lexington
Local Institution, Blois
Local Institution, Larissa
Pikeville Medical Center, Pikeville
Local Institution, Nantes
Local Institution, Toledo
Local Institution, Ioannina
Local Institution, Indianapolis
Local Institution, Mishawaka
Local Institution, Meldola
Local Institution, Rimini
Local Institution, Ravenna
Local Institution, Münster
Henry Ford Health System, Detroit
Local Institution, Petah Tikva
Local Institution, Florence
Local Institution, Cologne
Local Institution, Iowa City
Medical College of Wisconsin, Milwaukee
University Of Wisconsin Hospital And Clinics, Madison
Local Institution, Vandœuvre-lès-Nancy
Gundersen Clinic, Ltd, La Crosse
Local Institution, Bismarck
Local Institution, Lille
Local Institution, Hamm
Orchard Healthcare Research Inc., Skokie
Local Institution, Ancona
Washington University School Of Medicine, St Louis
Local Institution, Aschaffenburg
Capitol Comprehensive Cancer Care Center, Jefferson City
Local Institution, Springfield
Local Institution, Hamburg
Local Institution, Heidelberg
Local Institution, Pierre Benita
Local Institution, Ẕerifin
Cancer Center Of Acadiana At Lafayette General, Lafayette
Local Institution, Shreveport
Local Institution, Shreveport
Willis Knighton Cancer Center, Shreveport
Local Institution, Tübingen
University Of Oklahoma Health Sciences Center, Oklahoma City
Local Institution, Tulsa
Local Institution, Paris
Local Institution, Rehovot
University Of Texas Md Anderson Cancer Ctr, Houston
Northwest Cancer Center, Houston
Cancer Specialists Of South Texas, Pa, Corpus Christi
Local Institution, München
Local Institution, München
Acrc/Arizona Clinical Research Center, Inc., Tucson
Local Institution, La Roche-sur-Yon
Local Institution, Limoges
Local Institution, Ravensburg
Local Institution, Ulm
Local Institution, Las Vegas
Ucla-Division Of Hematology/Oncology, Los Angeles
Local Institution, Palermo
Local Institution, Jerusalem
Local Institution, Burbank
San Diego Pacific Oncology& Hematology Associates, Inc, Encinitas
Sharp Clinical Oncology Research, San Diego
Local Institution, Clamart
Medical Oncology Care Associates, Orange
Compassionate Cancer Res Grp, Corona
Local Institution, Corona
Local Institution, Vallejo
Local Institution, Berkeley
Local Institution, Greenbrae
Local Institution, Würzburg
Va Puget Sound Health Care System, Seattle
Local Institution, Brasov
Local Institution, Brasov
Local Institution, Bunkyo-Ku
Local Institution, Koto-ku
Local Institution, Shibuya-ku
Local Institution, Shinjuuku-ku
Local Institution, Shibukawa-shi
Local Institution, Toyohashi
Local Institution, Nagoya
Local Institution, Nagoya
Local Institution, Osaka
Local Institution, Okayama
Local Institution, Niigata
Dana Farber Cancer Inst, Boston
Dana-Farber Cancer Institute, Boston
Local Institution, Stony Brook
Ut Southwestern Medical Center, Dallas
Local Institution, Calgary
Local Institution, Edmonton
Local Institution, Halifax
Local Institution, London
Local Institution, Toronto
Local Institution, Montreal
Local Institution, Saskatoon
Local Institution, Barrie
Local Institution, Montreal
Local Institution, Brno
Local Institution, Hradec Králové
Local Institution, Prague
Local Institution, Prague
Local Institution, Chemnitz
Local Institution, Dresden
Local Institution, Jena
Local Institution, Debrecen
Local Institution, Szeged
Local Institution, Tullamore
Local Institution, Roma
Local Institution, Roma
Local Institution, Maebashi
Local Institution, Sapporo
Local Institution, Sendai
Local Institution, Kamogawa
Local Institution, Chiba
Local Institution, Fukuoka
Local Institution, Kyoto
Local Institution, Bialystok
Local Institution, Chorzów
Local Institution, Lublin
Local Institution, Poznan
Local Institution, Warsaw
Local Institution, Warsaw
Local Institution, Warsaw
Local Institution, Wroclaw
Local Institution, Ponce
Local Institution, San Juan
Local Institution, Bucaresti
Local Institution, Badalona-Barcelona
Local Institution, Ankara
Local Institution, Leicester
Local Institution, London
Local Institution, Manchester
Local Institution, Airdrie
Local Institution, Edinburgh
Local Institution, Nottingham
Local Institution, Sutton
Local Institution, Leeds
Local Institution, London
Local Institution, Newcastle upon Tyne
Lead Sponsor
Collaborators (1)
AbbVie
INDUSTRY
Bristol-Myers Squibb
INDUSTRY